Conference Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 198 - Innovations in Patient-Focused Clinical Trials
Type: Contributed
Date/Time: Monday, August 8, 2022 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract #320892
Title: Likelihood-Based Inferences for Hybrid Trials Incorporating Patient's Treatment Choice
Author(s): Rouba Chahine* and Inmaculada A Aban
Companies: RTI International and The University of Alabama at Birmingham
Keywords: Likelihood; Doubly randomized; two-stage random choice trials; exponential family
Abstract:

Patient’s treatment choice is increasingly being considered in clinical trials especially in pragmatic trials which aim to choose the best therapy for normal clinical practice. Additionally, with the creation of Patient-Centered Outcomes Research Institute (PCORI) through the Patient Protection and Affordable Care Act of 2010, more funds are being allocated to studies that center on patients. Previously published methods dealing with hybrid trials incorporating patient’s treatment choice either used ANOVA-based approach that does not allow for inclusion of covariates in the model or used likelihood methods with complex computations making it challenging for investigators to use. In our work, we propose a likelihood-based approach that can be applied to a broad class of distributions, allows for the inclusion of covariates in the model and multiple study arms, and can be executed using basic R functions. Using simulations, we evaluate these methods for a variety of continuous and categorical outcomes. Finally, we illustrate these methods by analyzing change in six-minute walking distance from a behavioral intervention study for women with heart disease.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2022 program